BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29870766)

  • 1. Ultrasound targeting of Q-starch/miR-197 complexes for topical treatment of psoriasis.
    Lifshiz Zimon R; Lerman G; Elharrar E; Meningher T; Barzilai A; Masalha M; Chintakunta R; Hollander E; Goldbart R; Traitel T; Harats M; Sidi Y; Avni D; Kost J
    J Control Release; 2018 Aug; 284():103-111. PubMed ID: 29870766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
    Doppalapudi S; Jain A; Chopra DK; Khan W
    Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting miR-21 to treat psoriasis.
    Guinea-Viniegra J; Jiménez M; Schonthaler HB; Navarro R; Delgado Y; Concha-Garzón MJ; Tschachler E; Obad S; Daudén E; Wagner EF
    Sci Transl Med; 2014 Feb; 6(225):225re1. PubMed ID: 24574341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
    Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
    Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
    Gungor S; Rezigue M
    Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
    Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
    Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.
    Marto J; Gouveia LF; Gonçalves LM; Gaspar DP; Pinto P; Carvalho FA; Oliveira E; Ribeiro HM; Almeida AJ
    Colloids Surf B Biointerfaces; 2016 Jul; 143():177-185. PubMed ID: 27003468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
    J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of transdermal magnesium ascorbyl phosphate delivery after ultrasound treatment with microbubbles in gel-type surrounding medium in mice.
    Liao AH; Lu YJ; Hung CR; Yang MY
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():591-8. PubMed ID: 26838887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An elastic liposomal formulation for RNAi-based topical treatment of skin disorders: Proof-of-concept in the treatment of psoriasis.
    Desmet E; Bracke S; Forier K; Taevernier L; Stuart MC; De Spiegeleer B; Raemdonck K; Van Gele M; Lambert J
    Int J Pharm; 2016 Mar; 500(1-2):268-74. PubMed ID: 26806466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.
    Bracke S; Desmet E; Guerrero-Aspizua S; Tjabringa SG; Schalkwijk J; Van Gele M; Carretero M; Lambert J
    Arch Dermatol Res; 2013 Aug; 305(6):501-12. PubMed ID: 23775225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
    Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
    J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-150 regulates human keratinocyte proliferation in hypoxic conditions through targeting HIF-1α and VEGFA: Implications for psoriasis treatment.
    Li Y; Su J; Li F; Chen X; Zhang G
    PLoS One; 2017; 12(4):e0175459. PubMed ID: 28399173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
    Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
    J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for psoriasis in the K14-VEGF transgenic mouse model by topical transdermal delivery of interleukin-4 using ultradeformable cationic liposome.
    Li J; Li X; Zhang Y; Zhou XK; Yang HS; Chen XC; Wang YS; Wei YQ; Chen LJ; Hu HZ; Liu CY
    J Gene Med; 2010 Jun; 12(6):481-90. PubMed ID: 20527041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
    Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
    Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.